NCT01135108View on ClinicalTrials.gov

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

May 31, 2010

Conditions
Spinal Cord Injury
Interventions
DRUG

Placebo

Placebo IV Infusion

DRUG

KAI-1678

KAI-1678 IV Infusion

Trial Locations (1)

Unknown

Sydney

Sponsors
All Listed Sponsors
collaborator

Trident Clinical Research Pty Ltd

INDUSTRY

lead

KAI Pharmaceuticals

INDUSTRY

NCT01135108 - Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury | Biotech Hunter | Biotech Hunter